Microbiome: An Emerging Field with Growing Investments

The potential of the microbiome to be used for the development of promising therapeutics and diagnostic approaches has spurred a hype around this emerging field. Over the last decade, researchers have found correlations between the human microbiome and a number of diseases, including inflammatory bowel disease, diabetes, autoimmune diseases, cancer, depression, and many more. As the number of clinical trials grows, investor interest is increasing. 

Read on to find out more about the flourishing microbiome field and how it shows promise for the treatment of a large variety of diseases.